Swiss National Bank’s Minerva Neurosciences NERV Stock Holding History

Swiss National Bank’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,525	Closed	-$467K	–	2525
2019 Q3	$467K	Hold	7,525	–	–	﹤0.01%	2380
2019 Q2	$339K	Hold	7,525	–	–	﹤0.01%	2499
2019 Q1	$473K	Buy	7,525 +350	+5%	+$21K	﹤0.01%	2383
2018 Q4	$387K	Hold	7,175	–	–	﹤0.01%	2430
2018 Q3	$720K	Hold	7,175	–	–	﹤0.01%	2304
2018 Q2	$474K	Hold	7,175	–	–	﹤0.01%	2459
2018 Q1	$359K	Buy	7,175 +750	+12%	+$36K	﹤0.01%	2441
2017 Q4	$311K	Hold	6,425	–	–	﹤0.01%	2488
2017 Q3	$391K	Buy	6,425 +1,425	+29%	+$81.7K	﹤0.01%	2434
2017 Q2	$354K	Hold	5,000	–	–	﹤0.01%	2496
2017 Q1	$324K	Hold	5,000	–	–	﹤0.01%	2473
2016 Q4	$470K	Buy	+5,000	New	+$510K	﹤0.01%	2420

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IVAI

Index Venture Associates IV St. Helier, Channel Islands, Jersey $6.24M AUM

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Swiss National Bank's NERV Position: Q4 2019 in Review

Swiss National Bank sold out of Minerva Neurosciences (NERV) in Q4 2019, closing a stake of 7,525 shares — an estimated $467K sold.

Swiss National Bank first reported a position in NERV in Q4 2016 and held it in 12 quarters. The position peaked at $720K in Q3 2018. 92 funds tracked by Wall St. Rank hold NERV as of Q4 2019.

Swiss National Bank reported no remaining Minerva Neurosciences position as of Q4 2019 after selling out during the quarter.
Swiss National Bank sold 7,525 Minerva Neurosciences shares in Q4 2019, an estimated $467K.
Swiss National Bank first reported a position in Minerva Neurosciences in Q4 2016 and held it in 12 quarters.
Swiss National Bank's Minerva Neurosciences position peaked at $720K in Q3 2018.
92 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2019.

Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.